U.S. Drug Makers, Others Urge Diplomatic Pressure On India Patent Policy
This article was originally published in PharmAsia News
Executive Summary
U.S. drug makers are taking the government-diplomacy route to pressure India to clean up its policy dealing with drug patents, first calling for pressure from the White House, then action before the World Trade Organization.